Provence Wealth Management Group Raises Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Provence Wealth Management Group lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 33.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,468 shares of the healthcare conglomerate’s stock after purchasing an additional 614 shares during the quarter. Provence Wealth Management Group’s holdings in UnitedHealth Group were worth $1,299,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently bought and sold shares of UNH. Bray Capital Advisors increased its stake in UnitedHealth Group by 0.5% during the 3rd quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after buying an additional 50 shares during the period. Litman Gregory Wealth Management LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at about $11,680,000. Live Oak Private Wealth LLC lifted its position in shares of UnitedHealth Group by 0.8% during the 3rd quarter. Live Oak Private Wealth LLC now owns 23,212 shares of the healthcare conglomerate’s stock worth $11,703,000 after purchasing an additional 179 shares during the last quarter. Hexagon Capital Partners LLC boosted its position in shares of UnitedHealth Group by 3.6% during the 3rd quarter. Hexagon Capital Partners LLC now owns 1,083 shares of the healthcare conglomerate’s stock worth $546,000 after acquiring an additional 38 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. boosted its holdings in shares of UnitedHealth Group by 5.4% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 131,333 shares of the healthcare conglomerate’s stock valued at $66,217,000 after acquiring an additional 6,777 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock traded down $0.52 on Friday, hitting $492.45. 2,487,811 shares of the stock traded hands, compared to its average volume of 5,130,659. The company has a market capitalization of $453.09 billion, a PE ratio of 30.10, a PEG ratio of 1.43 and a beta of 0.55. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company’s fifty day moving average is $482.32 and its 200 day moving average is $512.76. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.26 earnings per share. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.53%. UnitedHealth Group’s payout ratio is 45.97%.

Analyst Ratings Changes

A number of research firms have commented on UNH. HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price target on the stock in a research report on Thursday, April 4th. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research note on Friday, April 19th. TD Cowen decreased their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Royal Bank of Canada reduced their price objective on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 17th. Finally, Truist Financial reiterated a “buy” rating and issued a $600.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 17th. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.